220 related articles for article (PubMed ID: 36776838)
1. NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation.
Wang Q; Li Z; Zhou S; Li Z; Huang X; He Y; Zhang Y; Zhao X; Tang Y; Xu M
Front Immunol; 2023; 14():1097403. PubMed ID: 36776838
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2.
Feng H; Chen N; Li H; Zheng Z; Li H; Quan H; Jin X; Jiang P; Wu Q; Yang X
Heliyon; 2023 Jul; 9(7):e18051. PubMed ID: 37501987
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Prognostic and Immune Infiltration Analysis of RBM4 in Pan-Cancer.
Ding JJ; Wu J; Bian HL; Zong Y; Lu B; Ni L
Front Biosci (Landmark Ed); 2024 Feb; 29(2):89. PubMed ID: 38420804
[TBL] [Abstract][Full Text] [Related]
4. NCAPG2 promotes tumour proliferation by regulating G2/M phase and associates with poor prognosis in lung adenocarcinoma.
Zhan P; Xi GM; Zhang B; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu Q; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Lv TF; Song Y
J Cell Mol Med; 2017 Apr; 21(4):665-676. PubMed ID: 27862966
[TBL] [Abstract][Full Text] [Related]
5. LncRNA-AL035458.2/hsa-miR-181a-5p Axis-Mediated High Expression of NCAPG2 Correlates With Tumor Immune Infiltration and Non-Small Cell Lung Cancer Progression.
Chen X; Guo J; Ren W; Zhou F; Niu X; Jiang X
Front Oncol; 2022; 12():910437. PubMed ID: 35664767
[TBL] [Abstract][Full Text] [Related]
6. microRNA-375 inhibits the malignant behaviors of hepatic carcinoma cells by targeting NCAPG2.
Dai HT; Wang ST; Chen B; Tang KY; Li N; Wen CY; Wan Y; Zhang GY; Huang YH; Geng ZJ
Neoplasma; 2022 Jan; 69(1):16-27. PubMed ID: 34818025
[TBL] [Abstract][Full Text] [Related]
7. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
[TBL] [Abstract][Full Text] [Related]
8. NCAPG2 contributes to the progression of malignant melanoma through regulating proliferation and metastasis.
Feng Z; Zhang L; Liu Y; Zhang W
Biochem Cell Biol; 2022 Dec; 100(6):473-484. PubMed ID: 36265182
[TBL] [Abstract][Full Text] [Related]
9. NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma.
Ren W; Yang S; Chen X; Guo J; Zhao H; Yang R; Nie Z; Ding L; Zhang L
Front Oncol; 2022; 12():918606. PubMed ID: 35898895
[TBL] [Abstract][Full Text] [Related]
10. The mRNA stability of NCAPG2, a novel contributor to breast invasive carcinoma, is enhanced by the RNA-binding protein PCBP2.
Han S; Jin X; Hu T; Chi F
Cell Signal; 2023 Oct; 110():110844. PubMed ID: 37544634
[TBL] [Abstract][Full Text] [Related]
11. NIFK, a Potential Prognostic and Immunological Biomarker in Pan-- Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer.
Li Z; Zhou S; Bin T; Shi Y; Zeng L; Li B; Li J; He Y; Zhang C
Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38659266
[TBL] [Abstract][Full Text] [Related]
12. Brachyury promotes proliferation and migration of hepatocellular carcinoma via facilitating the transcription of NCAPG2.
Li S; Lu Y; Xu Y; Zhang C; Liu B; Qin A; Qiao Z; Shen C; Shen J; Liang Y; Wu J; Jiang X
Am J Cancer Res; 2022; 12(8):3625-3643. PubMed ID: 36119840
[TBL] [Abstract][Full Text] [Related]
13. Multi-Omics Analysis of the Oncogenic Value of Pituitary Tumor-Transforming Gene 1 (
Wang L; Liu X
Front Biosci (Landmark Ed); 2024 Feb; 29(2):87. PubMed ID: 38420810
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
15. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer.
Zhang S; Qin O; Xu H; Wu S; Huang W; Song H
Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634
[TBL] [Abstract][Full Text] [Related]
16. GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer.
Chen G; Luo D; Zhong N; Li D; Zheng J; Liao H; Li Z; Lin X; Chen Q; Zhang C; Lu Y; Chan YT; Ren Q; Wang N; Feng Y
Front Immunol; 2022; 13():857308. PubMed ID: 35345673
[TBL] [Abstract][Full Text] [Related]
17. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
18. A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma.
Huang S; Sun L; Hou P; Liu K; Wu J
Front Immunol; 2022; 13():944898. PubMed ID: 36148220
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer.
Shen Q; Li J; Zhang C; Pan X; Li Y; Zhang X; En G; Pang B
Aging (Albany NY); 2023 Sep; 15(18):9779-9796. PubMed ID: 37733696
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
